Night shift work disrupts the natural 24-hour rhythms in the activity of certain cancer-related genes, making workers more vulnerable to damage to their DNA.
Innovative technology combines continuous, remote, real-time testing and monitoring of byproduct gasses, paving the way for faster advanced reactor development and testing.
PNNL radiochemist and research manager Patricia Paviet named National Technical Director for the Molten Salt Reactor (MSR) Program by the U.S. Department of Energy’s Office of Nuclear Energy.
PNNL streamlines environmental review process for advanced reactors, saving years and millions of dollars toward deployments of new nuclear power projects.
PNNL computational biologists, structural biologists, and analytical chemists are using their expertise to safely accelerate the design step of the COVID-19 drug discovery process.
By studying discrete functional components of the soil microbiome at high resolution, researchers obtained a more complete picture of soil diversity compared to analysis of the entire soil community.
Six months into a pandemic that has claimed more than 570,000 lives worldwide, scores of PNNL scientists are engaged in dozens of projects in the fight against COVID-19.
Accurate identification of metabolites, and other small chemicals, in biological and environmental samples has historically fallen short when using traditional methods.
A new study using proteogenomics to compare cancerous tissue with normal fallopian tube samples advances insights about the molecular machinery that underlies ovarian cancer.
PNNL and Argonne researchers developed and tested a chemical process that successfully captures radioactive byproducts from used nuclear fuel so they could be sent to advanced reactors for destruction while also producing electrical power.
Steve Short, a nuclear engineer at Pacific Northwest National Laboratory, has been selected as a fellow of the National Society of Professional Engineers.